Northwick Park clinical drug trials - drug manufacturer Tegenero file for insolvency
05/07/2006
Thank you very much for the brilliant service, professionalism and caring attitude whilst handling my recent claim.
Vicki, Sheffield
Tegenero, the manufacturer of TGN1412 - the drug which left two men critically ill in hospital and a further four men injured yesterday filed for insolvency.
The drug company said that the drug trial of TGN1412 had made it impossible to attract the investment necessary for the company to continue operations.
Specialist clinical negligence solicitor Ann Alexander, who represents Ryan Wilson and Mohamed Abdelhady - the two most seriously injured participants - said:
"I am surprised that Tegenero they have chosen to file for insolvency before the compensation claims have been considered, thereby causing further alarm and psychological distress for our clients"
"However this should not affect in any way the claims our clients have following this tragic incident. We believe that there are good grounds against both Tegenero, who manufactured the drug, and Parexel who were responsible for managing the trial."
"I would also fiercely dispute the statement by Tegenero that the adverse reaction of our clients to this drug was unforeseeable. We believe there is increasingly strong scientific evidence which supports our view."
"The total liability limit on Tegenero's insurance is £2m, which is wholly inadequate."
"Drug companies need to be prepared if things go wrong at clinical trial. I am calling for greater scrutiny into the precautions drug companies should be made to take when carrying out clinical drug trials."
Back to news
If you would like us to provide you with advice with regard to your potential claim, please complete our brief claim form. We will reply to your enquiry within one working day.
Fill out our quick claim form
If you would like to speak to someone directly about your claim, please call our friendly team on:
0870 024 0558